News about "T-cell engager platform "

AbbVie and EvolveImmune to Develop Next-Gen Cancer Biotherapeutics

AbbVie and EvolveImmune to Develop Next-Gen Cancer Biotherapeutics

EvolveImmune's proprietary EVOLVE platform is designed to deliver potent, selective and integrated T-cell co-stimulation to amplify and sustain the tumor killing capacity of the T-cells.

T-cell Engager Platform | 01/11/2024 | By Aishwarya


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members